{"database": "lobbying", "table": "lobbying_activities", "rows": [[2461863, "615e7c3c-2939-4128-9b11-08791624ac32", "Q2", "BLUEBIRD STRATEGIES", 401105447, "PEAR THERAPEUTICS", 2020, "second_quarter", "MMM", "H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-07-07T14:18:45.297000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2461863"], "units": {}, "query_ms": 56.72007706016302, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}